ArticleClinicoEconomics and outcomes research : CEOR2025

Budget Impact and Cost-Benefit Analyses of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in Thailand.

Poukwan Arunmanakul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.